These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24338699)

  • 1. Economic burden and costs of chronic migraine.
    Lanteri-Minet M
    Curr Pain Headache Rep; 2014 Jan; 18(1):385. PubMed ID: 24338699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey.
    Messali A; Sanderson JC; Blumenfeld AM; Goadsby PJ; Buse DC; Varon SF; Stokes M; Lipton RB
    Headache; 2016 Feb; 56(2):306-22. PubMed ID: 26833083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
    Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
    Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Serrano D; Manack AN; Reed ML; Buse DC; Varon SF; Lipton RB
    Value Health; 2013; 16(1):31-8. PubMed ID: 23337213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS).
    Bloudek LM; Stokes M; Buse DC; Wilcox TK; Lipton RB; Goadsby PJ; Varon SF; Blumenfeld AM; Katsarava Z; Pascual J; Lanteri-Minet M; Cortelli P; Martelletti P
    J Headache Pain; 2012 Jul; 13(5):361-78. PubMed ID: 22644214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.
    Lipton RB; Manack Adams A; Buse DC; Fanning KM; Reed ML
    Headache; 2016 Sep; 56(8):1280-9. PubMed ID: 27349336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Lipton RB; Serrano D; Nicholson RA; Buse DC; Runken MC; Reed ML
    Headache; 2013; 53(10):1548-63. PubMed ID: 23992516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.
    Pradalier A; Auray JP; El Hasnaoui A; Alzahouri K; Dartigues JF; Duru G; Henry P; Lantéri-Minet M; Lucas C; Chazot G; Gaudin AF
    Pharmacoeconomics; 2004; 22(15):985-99. PubMed ID: 15449963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
    Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Headache-Free Days on Disability, Productivity, Quality of Life, and Costs Among Individuals with Migraine.
    Lipton RB; Lee L; Saikali NP; Bell J; Cohen JM
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1344-1352. PubMed ID: 32678720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. United States Patients' Perspective of Living With Migraine: Country-Specific Results From the Global "My Migraine Voice" Survey.
    Gibbs SN; Shah S; Deshpande CG; Bensink ME; Broder MS; Dumas PK; Buse DC; Vo P; Schwedt TJ
    Headache; 2020 Jul; 60(7):1351-1364. PubMed ID: 32369201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of migraine: societal costs and therapeutic opportunities.
    Lipton RB; Stewart WF; von Korff M
    Neurology; 1997 Mar; 48(3 Suppl 3):S4-9. PubMed ID: 9071263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
    Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
    Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study.
    Buse DC; Manack AN; Fanning KM; Serrano D; Reed ML; Turkel CC; Lipton RB
    Headache; 2012; 52(10):1456-70. PubMed ID: 22830411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Serrano D; Pavlovic JM; Manack AN; Reed ML; Turkel CC; Buse DC
    Headache; 2014 May; 54(5):830-49. PubMed ID: 24527745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of migraine in the United States: disability and economic costs.
    Hu XH; Markson LE; Lipton RB; Stewart WF; Berger ML
    Arch Intern Med; 1999 Apr; 159(8):813-8. PubMed ID: 10219926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
    Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
    Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of headache frequency and preventive treatment failure on quality of life, disability, and direct and indirect costs among individuals with episodic migraine in the United States.
    Dodick DW; Reed ML; Lee L; Balkaran BL; Umashankar K; Parikh M; Gandhi P; Buse DC
    Headache; 2024 Apr; 64(4):361-373. PubMed ID: 38523435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: a clinic-based study in Taiwan.
    Wang SJ; Wang PJ; Fuh JL; Peng KP; Ng K
    Cephalalgia; 2013 Feb; 33(3):171-81. PubMed ID: 23203506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden and costs of migraine in a Swedish defined patient population - a questionnaire-based study.
    Hjalte F; Olofsson S; Persson U; Linde M
    J Headache Pain; 2019 May; 20(1):65. PubMed ID: 31151382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.